Skip to main content
Main navigation
Our Company
Who we are
Senior Leadership Team
Board of Directors
Scientific Advisory Committee
Our Solutions
AGROBODY Foundry™
Product pipeline
Evoca™
Investors
Press releases
Financial information
Stock Information
Shareholder information
Corporate governance
Events
Presentations
Fact sheets
IPO
Partnering
News & Events
Press releases
Events
Stay in touch
Message from our CEO
Careers
Open Positions
Vision & Values
What our employees say
Benefits and wellbeing
Contact
User account menu
Log in
Press releases
Go back to Investors overview
Title
Sort by
Oldest
Latest
June 29, 2021
Biotalys Announces Coverage of the Base Offering Throughout the Price Range
EN
FR
NL
June 23, 2021
Biotalys launches its Initial Public Offering on Euronext Brussels
June 23, 2021
Biotalys launches its Initial Public Offering on Euronext Brussels
EN
FR
NL
June 17, 2021
Biotalys’ ongoing trial program demonstrates strong potential of its new generation protein-based biocontrols
EN
June 15, 2021
Biotalys announces Intention to Launch an Initial Public Offering on Euronext Brussels
EN
FR
NL
June 15, 2021
Biotalys announces Intention to Launch an Initial Public Offering on Euronext Brussels
June 10, 2021
Biotalys Nominates Catherine Moukheibir to its Board of Directors
May 4, 2021
Biotalys Earns Recognition in Fast Company’s 2021 World Changing Ideas Awards
April 20, 2021
Biotalys Appoints Simon Moroney as Chairman of the Board
March 25, 2021
Biotalys Files its First Protein-Based Biocontrol for Registration in the EU
January 21, 2021
Biotalys Submits First Protein-Based Biocontrol Registration Package to the EPA
October 1, 2020
Biotalys awarded €1.1 million VLAIO research grant
September 10, 2020
Biotalys Honored with Two AgTech Breakthrough Awards
July 9, 2020
Biotalys appoints Wim Ottevaere as Chief Financial Officer in preparation for global growth
June 9, 2020
Biotalys Expands Executive Team and Establishes U.S. Headquarters to Strengthen North American Presence
EN
Pagination
Previous page
<
…
Page
5
Current page
6
Page
7
Next page
>
Social Menu
Twitter
LinkedIn
Email